Literature DB >> 10030764

Effect of helium-oxygen on delivery of albuterol in a pediatric, volume-cycled, ventilated lung model.

D M Habib1, S S Garner, S Brandeburg.   

Abstract

Pulmonary delivery of inhaled bronchodilators in mechanically ventilated patients is inefficient whether administered by metered-dose inhaler (MDI) or small-volume nebulizer. One of the factors that causes inefficient aerosol delivery is turbulent gas. Heliox (He:O2) is a blend of helium and oxygen that is less dense than air, making turbulent flow less likely. We assessed the effect of 70% He:O2 on albuterol delivery in a mechanically ventilated pediatric lung model. Albuterol was administered by MDI with spacer, collected on a filter proximal to a test lung, and measured by high-performance liquid chromatography. Mean amount and percentage albuterol delivered were significantly (p<0.05) greater for 70% He:O2 (395+/-29 microg, 20+/-3.2%) than for 70% nitrogen:30% oxygen (241+/-29 microg,12+/-1.7%). Thus 70% He:O2 can increase the amount of albuterol delivered at the end of the endotracheal tube, suggesting a potential role for it in the care of critically ill ventilated patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10030764     DOI: 10.1592/phco.19.3.143.30920

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  2 in total

1.  Two administration methods for inhaled salbutamol in intubated patients.

Authors:  S S Garner; D B Wiest; J W Bradley; D M Habib
Journal:  Arch Dis Child       Date:  2002-07       Impact factor: 3.791

2.  Fatal and near-fatal asthma in children: the critical care perspective.

Authors:  Christopher J L Newth; Kathleen L Meert; Amy E Clark; Frank W Moler; Athena F Zuppa; Robert A Berg; Murray M Pollack; Katherine A Sward; John T Berger; David L Wessel; Rick E Harrison; Jean Reardon; Joseph A Carcillo; Thomas P Shanley; Richard Holubkov; J Michael Dean; Allan Doctor; Carol E Nicholson
Journal:  J Pediatr       Date:  2012-04-10       Impact factor: 4.406

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.